Foster Jonathan P. reported MBRX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001437749-26-035617

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 4, 2026

Published

Nov 6, 2026

Ingested by INSIDER

Nov 6, 22:10 UTC

Last re-read

Nov 7, 15:04 UTC

Extracted facts

Filer

Foster Jonathan P.

Role

Chief Financial Officer

Transaction

Option exerciseAs filed: “M”

Asset

Moleculin Biotech, Inc.

Ticker

MBRX

Shares

41

Execution date (reported)

Nov 4, 2026

Owned after transaction

20.3K shares

Days from execution to publication

2

What this establishes

Foster Jonathan P. filed this Form 4 reporting a option exercise of MBRX on Nov 4, 2026. It became public on Nov 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Financial Officer

Foster Jonathan P.cik:0001545414

Issuer

Moleculin Biotech, Inc.cik:0001659617

Revision history · 0

No field has changed since this record was first ingested.